Insmed Inc - Company Profile
Powered by
All the data and insights you need on Insmed Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Insmed Inc Strategy Report
- Understand Insmed Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Insmed Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP3883590A4 | Search Report | GLYCOPEPTIDDERIVATVERBINDUNGEN UND VERWENDUNGEN DAVON | A61K38/00; A61P31/04; C07K9/008 | September 21, 2022 |
AU2018273887B2 | Grant | Lipo-glycopeptide cleavable derivatives and uses thereof | A61K38/14; A61K47/54; A61K9/0019; A61K9/0073; A61K9/0075; A61K9/0078; A61K9/008; A61K9/08; A61K9/10; A61K9/1617; A61K9/19; A61K9/5123; A61K9/5153; A61P31/04; C07K9/008 | September 08, 2022 |
CA2927788C | Grant | PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | A61K31/165; A61K31/216; A61K31/225; A61K31/5585; A61K47/06; A61K47/14; A61K47/24; A61K47/28; A61K47/34; A61K47/543; A61K47/544; A61K47/60; A61K47/6907; A61K47/6929; A61K9/0019; A61K9/0043; A61K9/0053; A61K9/0073; A61K9/0075; A61K9/0078; A61K9/10; A61K9/14; A61K9/51; A61M15/0085; A61M15/009; A61M16/14; A61M2202/064; A61P11/00; A61P9/12; C07C235/20; C07C235/22; C07C2601/18; C07C2603/14; C07C69/712; C07C69/734; C07C69/736; C07C69/753 | September 06, 2022 |
GB2577419B | Grant | Lipo-glycopeptide cleavable derivatives and uses thereof | A61K38/14; A61K47/54; A61K9/00; A61K9/0019; A61K9/0073; A61K9/0075; A61K9/0078; A61K9/008; A61K9/08; A61K9/10; A61K9/1617; A61K9/19; A61K9/5123; A61K9/5153; A61P31/04; C07K9/008 | August 17, 2022 |
JP2022115951A | Application | 気管支拡張症の処置のための特定の(2S)-N-[(1S)-1-シアノ-2-フェニルエチル]-1,4-オキサゼパン-2-カルボキサミド | A61K31/553; A61K9/0053; A61P11/00; A61P31/04; C07D413/12 | August 09, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer